Cargando…
Design of New Competitive Dengue Ns2b/Ns3 Protease Inhibitors—A Computational Approach
Dengue is a serious disease which has become a global health burden in the last decade. Currently, there are no approved vaccines or antiviral therapies to combat the disease. The increasing spread and severity of the dengue virus infection emphasizes the importance of drug discovery strategies that...
Autores principales: | Frimayanti, Neni, Chee, Chin Fei, Zain, Sharifuddin M., Rahman, Noorsaadah Abd. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083692/ https://www.ncbi.nlm.nih.gov/pubmed/21541045 http://dx.doi.org/10.3390/ijms12021089 |
Ejemplares similares
-
Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1
por: Rothan, Hussin A, et al.
Publicado: (2012) -
Protegrin-1 Inhibits Dengue NS2B-NS3 Serine Protease and Viral Replication in MK2 Cells
por: Rothan, Hussin A., et al.
Publicado: (2012) -
Validation of Quantitative Structure-Activity Relationship (QSAR) Model for Photosensitizer Activity Prediction
por: Frimayanti, Neni, et al.
Publicado: (2011) -
Development of a NS2B/NS3 protease inhibition assay using AlphaScreen(®) beads for screening of anti-dengue activities
por: Abduraman, Muhammad Asyraf, et al.
Publicado: (2018) -
Designing cyclic peptide inhibitor of dengue virus NS3-NS2B protease by using molecular docking approach
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)